Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Orchid Wins First Certification for HLA Testing

Facebook Twitter LinkedIn Email Comments
PRINCETON, N.J., Sept. 20 -- Orchid BioSciences Inc. said that its GeneScreen business unit has received certification by the American Society of Histocompatibility and Immunogenetics (ASHI) to conduct commercial human leukocyte antigen (HLA) testing on the LabMap platform of Luminex Corp. Orchid is the first CLIA-approved laboratory to be awarded this accreditation, which it expects will allow it to significantly reduce turn-around time for its HLA-DR tissue typing services both for single-sample testing and for donor recruitment drives. HLA typing is the first step for patients and potential donors in the matching process for stem cell transplantation.

Luminex's open platform LabMap technology can perform up to 100 assays simultaneously on a small quantity of DNA with the capability for both medium and high throughput assay applications. This system combines the use of cost effective microsphere-based assays with small lasers, advanced digital signal processors and proprietary software to offer greater speed, precision and flexibility over other bioassay technologies.
Sep 2001
News & Features

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.